Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Amedisys, Inc. AMED NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
60/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$143.38
+42%

Amedisys, Inc. (AMED) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $100.99. It has a SharesGrow Score of 60/100, indicating a above average investment profile with 1 out of 7 criteria passed.

Analyst consensus target is AMED = $143 (+42% upside).

Financials: revenue is $2.3B, +2%/yr average growth. Net income is $43M, growing at +130.7%/yr. Net profit margin is 1.8% (thin). Gross margin is 43.3% (-1 pp trend).

Balance sheet: total debt is $460M against $1.1B equity (Debt-to-Equity (D/E) ratio 0.41, conservative). Current ratio is 1.23 (adequate). Debt-to-assets is 21.5%. Total assets: $2.1B.

Analyst outlook: 8 / 28 analysts rate AMED as buy (29%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 57/100 (Partial), Growth 73/100 (Pass), Past 75/100 (Partial), Health 67/100 (Partial), Moat 63/100 (Partial), Future 52/100 (Partial), Income 30/100 (Fail).

$143.38
▲ 41.97% Upside
Average Price Target
Based on 28 Wall Street analysts offering 12-month price targets for Amedisys, Inc., the average price target is $143.38, with a high forecast of $190.00, and a low forecast of $85.00.
Highest Price Target
$190.00
Average Price Target
$143.38
Lowest Price Target
$85.00

AMED SharesGrow Score Overview

60/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 57/100
Valuation — P/E, PEG, Forward PEG
GROWTH 73/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 63/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — AMED

~
VALUE Partial
57/100
AMED trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $143, implying +41.6% from the current price $101. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
73/100
AMED: +2%/yr revenue is, +130.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
AMED: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet AMED: Debt-to-Equity (D/E) ratio 0.41 (conservative), Current ratio is 1.23 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
63/100
AMED: Gross margin is 43.3% (-1 pp trend), $3B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 63/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 8 / 28 analysts rate AMED as buy (29%). Analyst consensus target is $143 (+41.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
30/100
AMED: Net profit margin is 1.8%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range82.15-101.02
Volume1.04M
Avg Volume (30D)517.9K
Market Cap$3.32B
Beta (1Y)0.90
Share Statistics
EPS (TTM)1.32
Shares Outstanding$32.72M
IPO Date1994-08-17
Employees19,000
CEORichard M. Ashworth
Financial Highlights & Ratios
Revenue (TTM)$2.35B
Gross Profit$1.02B
EBITDA$73.45M
Net Income$43.23M
Operating Income$94.54M
Total Cash$303.24M
Total Debt$460.18M
Net Debt$156.94M
Total Assets$2.14B
Price / Earnings (P/E)76.5
Price / Sales (P/S)1.41
Analyst Forecast
1Y Price Target$162.50
Target High$190.00
Target Low$85.00
Upside+60.9%
Rating ConsensusHold
Analysts Covering28
Buy 29% Hold 64% Sell 7%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS0234361089

Price Chart

Track all markets on TradingView
AMED
Amedisys, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Care Facilities
82.15 52WK RANGE 101.02

People Also View

UHS
UHS
Universal Health Services, Inc.
$181.95
-0.68%
 ENSG
ENSG
The Ensign Group, Inc.
$198.45
-0.92%
 EHC
EHC
Encompass Health Corporation
$106.70
-0.80%
 OPCH
OPCH
Option Care Health, Inc.
$27.90
-3.56%
 NHC
NHC
National HealthCare Corporation
$163.50
-3.60%
 ACHC
ACHC
Acadia Healthcare Company, Inc.
$26.56
+0.04%
 ADUS
ADUS
Addus HomeCare Corporation
$93.23
-1.96%
 SGRY
SGRY
Surgery Partners, Inc.
$13.10
+0.08%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message